Michael Heuser

Palbociclib in Acute Leukemias with KMT2A-rearrangement: Results of AMLSG 23-14 Trial

...

KIT D816 Mutated/CBF-negative Acute Myeloid Leukemia: a Poor-risk Subtype Associated with Systemic Mastocytosis

...

In Vivo Kinetics of Early, Non-random Methylome and Transcriptome Changes Induced by DNA-hypomethylating Treatment in Primary AML Blasts

Abstract: Despite routine use of DNA-hypomethylating agents (HMAs) in AML/MDS therapy, their mechanisms of action are not yet unraveled. Pleiotropic e...